RB/T 129-2022 Active Industry standards-Certification and accreditation

RB/T 129-2022 Guideline on the external quality assessment schemes in clinical molecular pathology

RB/T 129-2022 Guideline on the external quality assessment schemes in clinical molecular pathology

Publish Date: 2022-10-11 Implement Date: 2023-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Basic Information

Standard Code: RB/T 129-2022
Standard Type: Industry standards
Standard Status: Active
is_force_gb: no
CCS Name: Standardized management and general provisions
ICS Name: Product certification, institutional certification, and conformity assessment
Publish Date: 2022-10-11
Implement Date: 2023-01-01
Publisher: 国家认证认可监督管理委员会
Technical Committee: 国家认证认可监督管理委员会
Pages: 16 pages

Scope

本文件给出了室间质量评价项目所需的资源、项目的设计、室间质量评价物品、数据分析和结果评价、报告以及运作的指导。
本文件适用于组织和实施基于组织和细胞的临床分子病理临床分子病理室间质量评价项目的组织、实施和管理。

Development Information

Drafting Units:

中国合格评定国家认可中心、中国医学科学院北京协和医院、广东省人民医院、江苏省人民医院、中国认证认可协会

Drafting Persons:

贾汝静、梁智勇、王文泽、傅斌友、刘艳辉、张智弘、王腊梅、曹实

Word Count: 25 Thousand words Pages: 16 pages

Referenced Standards

Related Standards

Contact Us